Abiopharma

News list

Director BUZBY DAVID S 🟡 adjusted position in 0 shares (1 derivative) of STEM, INC. (STEM) Transaction Date: Aug 07, 2026 | Filing ID: 000004

Full text

News bot Aug. 12, 2026, 1:22 a.m.
🔍 BUZBY DAVID S (Director)

Company: STEM, INC. (STEM)

Report Date: 2026-08-07
Transaction Summary:
- Total transactions: 4
- Derivative instruments: 1
- Holdings reported: 2
- Total shares acquired: 7,486
- Total shares sold: 7,486
- Total shares held: 43,560
Detailed Transactions and Holdings:
- Acquired 7,486 shares of Common Stock, Par Value $0.0001 Per Share (Direct)
  Date: 2026-08-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 7,486.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock, Par Value $0.0001 Per Share (Direct)
  Date: 2026-08-07 | Code: H | nature_of_ownership: By the David S. Buzby Revocable Trust | shares_owned_after: 38,745.00 | Footnotes: F2
- Holds 0 shares of Common Stock, Par Value $0.0001 Per Share (Direct)
  Date: 2026-08-07 | Code: H | nature_of_ownership: By the David Buzby Roth IRA | shares_owned_after: 4,815.00
- Sold 7,486 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-07 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F3, F3
Footnotes:
- F1: Each restricted stock unit ("RSU") converted into a share of common stock on a one-for-one basis.
- F2: Held by the 2016 David S. Buzby Revocable Trust, of which the reporting person is sole trustee.
- F3: On June 4, 2025, the reporting person was granted 7,486 RSUs vesting 100% on August 7, 2026.